AIMT
Aimmune Therapeutics, Inc.
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
165 hedge funds and large institutions have $824M invested in Aimmune Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 22 closing their positions.
Holders
165
Holders Change
+4
Holders Change %
+2.48%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
72
Reduced
37
Closed
22
Calls
$8.67M
Puts
$5.11M
Net Calls
+$3.55M
Net Calls Change
+$2.3M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$62.2M |
| 2 |
2
First Manhattan
New York
|
$17.1M |
| 3 |
AC
3
Armistice Capital
New York
|
$15.4M |
| 4 |
SCA
4
Southpoint Capital Advisors
New York
|
$5.01M |
| 5 |
5
BlackRock
New York
|
$65.6M |
